logo-loader
RNS
capAI PLC

capAI PLC - Soft Launch of Author42

RNS Number : 8883H
capAI PLC
18 November 2025
 

THIS ANNOUNCEMENT ("ANNOUNCEMENT") AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS STATES, TERRITORIES AND POSSESSIONS ("UNITED STATES"), AUSTRALIA, CANADA, JAPAN, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY ANY APPLICABLE LAW.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND ("UK") PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

18 November 2025

capAI plc

(the "Company" and, together with its subsidiaries and subsidiary undertakings, the "Group" or "capAI")

 

Soft Launch of Author42

 

capAI plc (LSE: CPAI; OTCQB: CPIQF) is pleased to announce the soft launch of Author42, an advanced generative‑AI platform designed to revolutionise non-fiction book creation for authors, editors and publishing teams. Developed by the Company's U.S. subsidiary, capMedia Inc. ("capMedia"), Author42 combines market‑driven insight, AI‑scaffolding and professional editorial workflows into a unified author‑centric offering.

 

Public Beta Completed: Transition to Soft Launch

 

The soft launch follows a 12-week public beta programme, during which the platform's core systems operated in a live environment and the Company completed its planned evaluation of Author42's functionality, stability, and overall readiness of the platform's rollout.

 

A Platform Built for Professional Authoring

 

Author42 empowers authors from idea through publication with the following key capabilities:

 

·      AI‑Powered Book Blueprint: Generates a custom book proposal and table of contents - complete with 10 scaffolded chapters - based on the author's idea and real-time market research, providing structure from the start.

·      Market Demand Validation: Confirms whether the chosen topic has real commercial potential before significant writing effort is invested.

·      Author‑Driven Drafting: Authors retain full structural and content control - whether writing independently or co‑drafting with AI assistance.

·      Export‑Ready Formatting: Generation of EPUB, PDF and DOCX files, ready for submission to publishers, agents or self‑distribution.

 

CLARA42: Embedded Professional Editing Intelligence

 

A standout feature of the Author42 platform is CLARA42 (Creative Literary Assistance for Real Authors), an embedded editorial engine that delivers professional three-tier editing.

 

CLARA42 ensures every manuscript meets the highest industry standards through:

 

·      Developmental (Structural) Editing: In-depth analysis of book architecture, logic, and argument flow.

·      Line Editing: Sentence-level refinement to enhance clarity, tone, and impact.

·      Copy Editing (Style Compliance): Full alignment with The Chicago Manual of Style, producing publisher-ready output.

 

"With CLARA42 integrated into Author42, we bring professional editing within reach of every author," said Jayne Lytel, AI Architect at capMedia. "It's more than spelling and grammar; it's about structure, flow, and stylistic polish, delivered by AI trained on real editorial standards."

 

Benefits for Authors

 

Key benefits for authors include:

 

·      finishing manuscripts up to 60% faster;

·      reducing planning time from months to days;

·      publishing books aligned with reader demand (not just author ambition);

·      validating topics before the effort is committed; and

·      increasing completion rates and positioning authors for publisher acceptance with fully compliant outputs.

 

"Author42 gives authors real‑time clarity and structure," said Lytel. "Rather than being paralysed by a blank page, authors are now supported by live market intelligence, AI‑scaffolding and professional editorial workflows, so they move confidently from idea to finished manuscript."

 

Soft Launch: Final Stage Before Commercial Release

 

The soft launch introduces Author42 to a controlled early-access cohort as the Company prepares for full commercial rollout. This phase will:

 

·      validate onboarding flows at scale;

·      refine editorial and IP-development workflows;

·      test pricing, packaging, and customer-support readiness; and

·      complete final platform optimisation prior to general release.

 

The Company expects to move from soft launch to full commercial availability following completion of this structured evaluation period.

 

Pricing and Availability

 

Authors may access the platform at https://www.author42.com.

 

Author42 is offered through a tiered subscription structure, beginning with a free plan and paid plans from US$20 per month. All paid tiers include a 7-day free trial. Higher-tier plans provide increased functionality, greater token and word capacity, and access to more advanced export formats and tools. Full pricing details are available at https://www.author42.com/pricing.

 

Fiction

 

Architectural work is underway to expand to serve fiction authors with AI-assisted world-building, character development, and VOICE42 (Voice Optimization & Idiolect Calibration Engine), a breakthrough feature that creates character-specific linguistic models from uploaded profiles.

 

While competitors flag inconsistencies, VOICE42 generates or refines dialogue and narration to maintain each character's distinct voice, eliminating "on-the-nose" exchanges and creating the layered subtext that defines literary quality.

 

The fiction components of the platform are expected to become available in early 2026, subject to ongoing development and testing.

 

Comment

 

Professor Ronjon Nag, Executive Director of capAI plc, commented:


"The conclusion of the beta phase reflects a significant period of focused work behind the scenes as we advanced the core technology and underlying IP of the Author42 platform. I would like to thank our investors for their patience and continued support during this development cycle. In my view, this has been a value-accretive period for the Company in terms of strengthening our IP base and preparing Author42 for wider commercial deployment. With the planned additions of Creator42 and Game42 in due course, we expect the broader platform ecosystem to enhance the economics available to authors and expand the opportunities for IP development."

 

For the purposes of UK MAR, the person responsible for arranging release of this Announcement on behalf of capAI is Richard Edwards, Executive Chairman.

 

Enquiries

 

Company:

capAI plc hello@capaiplc.com

 

Broker Enquiries:

AlbR Capital Limited Tel: +44 (0) 207 469 0930

 

Important Legal Information

 

The information contained in this Announcement is for background purposes only and does not purport to be full or complete, nor does this Announcement constitute or form part of any invitation or inducement to engage in investment activity. No reliance may be placed by any person for any purpose on the information contained in this Announcement or its accuracy, fairness or completeness. The contents of this Announcement are not to be construed as legal, financial or tax advice.

 

This Announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities, nor shall it (or any part of it), or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor.

 

This Announcement may include forward-looking statements, which are based on current expectations and projections about future events, including about the Group's operations, strategy, financial performance, development milestones, and the future prospects of its business divisions, including capMedia and the Author42 platform. These statements may include, without limitation, any statements preceded by, followed by or including words such as "target", "believe", "expect", "aim", "intend", "may", "anticipate", "estimate", "plan", "project", "will", "can have", "likely", "should", "would", "could" and any other words and terms of similar meaning or the negative thereof.

 

Forward-looking statements are based on current expectations and are subject to various risks and uncertainties that could cause actual outcomes to differ materially. These risks include, but are not limited to: successful execution of definitive agreements; regulatory approvals; development timelines; market acceptance; technological shifts; and broader economic conditions. No representation or warranty is made or will be made that any forward-looking statement will come to pass, and no assurance can be given that any forward-looking statement will prove accurate. Except as required by law, capAI undertakes no obligation to revise or update any forward-looking statement. The forward-looking statements in this Announcement speak only as at the date of this Announcement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPKOBQDBDBPDD
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

7 min read